Brief: Oncolytics Biotech Reports Quarterly Diluted Loss Per Share Were $0.04
08/05/2020 12:29
May 8 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH INC - QTRLY BASIC EARNINGS AND DILUTED
LOSS
PER SHARE WERE $0.01 AND $0.04
* ONCOLYTICS BIOTECH INC - AS AT MARCH 31, 2020, COMPANY
REPORTED
$30.6 MILLION IN CASH AND CASH EQUIVALENTS
Source text for Eikon: ID:nCNWc3x7ka
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer